Valiant Laboratories Limited — Board Meeting, 08-08-2025: Outcome of Board Meeting

Valiant Laboratories has announced a board meeting where its Board of Directors approved the audited consolidated financial results for the quarter ended June 30, 2025 (Q1 FY25). The company recorded a total income of ₹47.48 crore and a net profit of ₹1.82 crore for the quarter. Basic earnings per share (EPS) for Q1 FY25 stood at ₹0.42. Investors should note these key financial highlights as no other major operational or strategic updates were reported from the meeting.